Although conjunctival goblet cells are a major cell type in ocular mucosa, their responses during ocular allergy are largely unexplored. This review summarizes the recent findings that provide key insights into the mechanisms by which their function and survival are altered during chronic inflammatory responses, including ocular allergy.
INTRODUCTION
Ocular allergy, a type of chronic inflammation, is a complex disease involving multiple target tissues, whose reactions are coordinated in response to allergens. The allergic stimulus, such as pollen in seasonal allergic conjunctivitis, interacts first with the corneal and conjunctival epithelial cells. The stimulus subsequently crosses the epithelium into the stroma, where activation of immune cells including mast cells, eosinophils, dendritic cells, T cells, and macrophages occurs. The responses of the different activated cells both in the epithelium and in stroma contribute to the final symptomatic responses of ocular chemosis, conjunctival injection, tear production, and lid swelling. In severe types of allergy, corneal damage can also occur.
Conjunctiva is a component of ocular mucosal surface that provides a barrier against the external environment. Similarly to other mucosal surfaces, the ocular surface is persistently exposed to allergens and commensal bacteria that pose a risk of inflammation and infection. The specialized epithelial cells, the stratified squamous and goblet cells, as well as conjunctival immune cells form a barrier that segregates host tissue from environmental factors. Both epithelial cells and immune cells together respond to external stimuli and provide protection by coordinating appropriate immune responses.
A major unexplored area in ocular allergy to be addressed by the present review is the response of a major cell type in the conjunctival epithelium, the goblet cells, to inflammatory and allergic mediators. We highlight the research demonstrating that conjunctival goblet cells are a direct target of cytokines and chemokines produced during chronic inflammatory and allergic responses, and that these cells respond by increasing the production of the large gel-forming mucin MUC5AC that functions to protect the ocular surface and remove allergens or other inflammatory stimuli from the tear film. Mucin produced by the goblet cells and secreted into the tears would be an additional symptom altered in chronic inflammation and allergic conjunctivitis contributing to the disease.
STRUCTURE AND FUNCTION OF CONJUNCTIVAL GOBLET CELLS
The conjunctiva consists of two major cell types, goblet cells and stratified squamous cells. Goblet cells occur singly or in clusters and are surrounded by stratified squamous cells. To date, these two cell types differ in the types of mucins present and released into the tear film. Stratified squamous cell synthesize the membrane-spanning mucins MUC1, MUC4, and MUC16 that are trafficked to the plasma membranes [1] . The mucin MUC4 predominates in the conjunctival stratified squamous cells [2] . In contrast to the stratified squamous cells, goblet cells synthesize and secrete a large, gel-forming mucin, the high molecular weight mucin MUC5AC. MUC5AC is secreted into the tear film, where it is the scaffold forming the mucous layer that overspreads the glycocalyx and the underlying epithelium. Experimental evidence shows that this layer is a gel [3] . MU5AC can trap ocular allergens including pollen and other airborne pathogens, and remove them from the surface of the eye transporting them into the lacrimal drainage system. MUC5AC is very protective for the ocular surface as chronic inflammatory diseases in which goblet cells are depleted show corneal and conjunctival damage [4, 5] .
CONJUNCTIVAL IMMUNE CELLS
Along with the antimicrobial peptides in the tears, innate cells within the conjunctiva like macrophages, mast cells, neutrophils, and natural killer T (NKT) cells afford protection by responding to allergens or microbes. Moreover, adaptive immune cells like T and B lymphocytes are present in the conjunctiva either diffusely distributed through epithelial or stromal layers or in loosely organized follicular structures, together forming conjunctiva-associated lymphoid tissue (CALT). The presence of such CALT has been reported in both rodents and humans [6 && ,7,8] . Whereas CALT is a normal and noninflammatory component of the ocular surface in human conjunctiva, in mice CALT is detected in response to antigenic challenge. Organized follicles of mouse CALT contain T and B lymphocytes and follicular dendritic cells (Fig. 1 [11, 12] . Close proximity of CALT persistently exposes the epithelial cells to immune mediators released in response to external stimuli. Exposure to different mediators or stimuli alters the secretory function of epithelial cells, leading to changes in their barrier function.
Conjunctival epithelial and especially goblet cell responses to chronic inflammatory mediators including those produced in ocular allergy are the focus of the present review.
RESPONSES TO CHRONIC INFLAMMATION
As a part of immune surveillance, tissue innate immune cells induce an acute inflammatory
KEY POINTS
Conjunctival goblet cell secretion, proliferation, and survival are direct targets of allergic and inflammatory mediators.
Preclinical mouse models of ocular allergy and chronic inflammation along with conjunctival goblet cells in culture provide a unique opportunity to study goblet cells responses during these chronic ocular surface diseases.
Cytokines like IFN-g, IL-17A, and IL-13 are produced by both innate and adaptive immune effectors as a part of protective mucosal immunity and when unresolved contribute to chronic disease.
Acute inflammatory responses involving cytokine IL-6 may induce goblet cell hyperplasia and mucin hypersecretion, but chronic inflammation involving IFN-g and TNF-a is associated with loss of goblet cells and mucin secretion. 
Cytokines expressed in the conjunctiva
Both innate and adaptive immune cells are capable of expressing the inflammatory cytokines. Ligation of Toll-like receptors on innate cells and epithelial cells by allergens or microbes induces secretion of proinflammatory cytokines such as IL-1b, TNF-a, and IL-6 as evidenced in a rodent model of lipopolysaccharide-mediated conjunctivitis [17] . Increased expression of TNF-a and IL-6 is also reported in chronic conjunctival inflammation associated with autoimmune Sjögren's syndrome [10 & ]. Following infections at mucosal sites, gd T cells, RORgt þ NK cells, and neutrophils are reported to express IL-17A [18] . Stressed epithelial cells can also induce local secretion of IFN-g by gd T cells [19] . Expression of IL-13 by the NKT cells at mucosal surfaces is detected during autoimmune responses [16 && ]. Under normal conditions, these cytokines are part of the protective responses that enhance antimicrobial activity, expression of chemokines that induce recruitment of neutrophils and mucin secretion [18, 19] . When left unresolved, such innate responses contribute to chronic conjunctivitis associated with diseases like allergic vernal keratoconjunctivitis (VKC) or autoimmune Steven-Johnson syndrome or Sjögren's syndrome [10 & ,20,21] . Cytokines like IFN-g (Th1), IL-17 (Th17), and IL-13 (Th2) are also associated with corresponding adaptive immune effector subsets detected during allergic or mucosal autoimmune responses [22] . However, the exact cellular source of these cytokines in the conjunctiva remains to be determined. 
Goblet cell responses
Although contribution of goblet cell hyperplasia and mucus hypersecretion to mucosal tissue disease has been examined extensively in pulmonary and gastric mucosa, there is a paucity of knowledge regarding conjunctival goblet cell responses. A typical clinical sign of a chronic disease like VKC is thick mucoid discharge; however, there are few studies detailing its correlation with conjunctival goblet cell numbers and their mucous production [23, 24] . Similarly in autoimmune Sjögren's syndrome, significantly reduced expression of goblet-cell-derived mucin, MUC5AC, has been correlated with the observed decline in conjunctival goblet cell number, but exact changes induced by acute and chronic inflammatory stimuli are not clear. One of the primary reasons for lack of this information is the unavailability of homogenous conjunctival goblet cell cultures until recently. In the last year, an adaptation of an original protocol developed by Dartt et al. [25] helped generate mouse goblet cell cultures [16 && ], which like colonic goblet cell line HT-29 express MUC5AC (Fig. 2) . These primary cultures also express cytokeratin-7 (CK-7) specifically associated with goblet cells, but not cytokeratin-4 (CK-4) found in the stratified squamous epithelium of conjunctiva, confirming their homogeneity. Moreover, cultured cells also respond to cholinergic stimulation by carbachol by increasing their secretion of MUC5AC and express receptors for inflammatory cytokines such as IFN-g, TNF-a, IL-6, IL-17A, and IL-13, thereby facilitating the assessment of effects of inflammatory mediators (Fig. 3) . Exposure of both IFN-g and TNF-a cultured mouse goblet cells inhibits their carbachol-stimulated MUC5AC secretion and induces apoptotic cell death. These changes in goblet cell responses in vitro explain the pathologic mechanism underlying reduced conjunctival goblet cell density and secreted tear MUC5AC levels during autoimmune Sjögren's syndrome in mice and humans [10 & ,13] . Primary goblet cell culture exposure to cytokines IL-6 and IL-13 induced their proliferation; however, interestingly only the former enhanced MUC5AC secretion. Thus, IL-6 expressed in response to microbial stimuli may indeed facilitate microbial clearance as a part of the normal defense mechanism. Moreover, it is also apparent that in allergic diseases IL-13 may be associated only with goblet cell hyperplasia and not mucin hypersecretion. These observations further suggest potential efficacy of anti-IL-6 or anti-IL-13 treatment in relieving the clinical signs of ocular allergies resulting from goblet cell hyperplasia.
CK-
Increased expression of IL-13 was also noted in the ocular mucosa in a mouse model of Sjögren's syndrome, similar to that reported in other mucosal autoimmune diseases [16 && ]. The significant decline in conjunctival goblet cells in this model as seen in Sjögren's patients precedes a period of goblet cell hyperplasia, with no corresponding increase in tear MUC5AC levels. The in-vitro responses of cultured goblet cells now lend a plausible explanation to such disease. Whereas elevated IL-13 expression in the conjunctiva may induce goblet cell proliferation and increase their numbers, the concomitantly increased expression of IFN-g and TNF-a may induce goblet cell death, and therefore a sharp decline in their numbers in chronic diseases like Sjögren's syndrome. On the basis of these observations, anti-IL-13 or anti-IL-6 therapeutic approaches can be speculated to be ineffective in autoimmune conjunctivitis. This example illustrates how preclinical mouse models of conjunctivitis and availability of primary mouse goblet cell culture provide an opportunity to evaluate and understand the goblet cell responses to acute and chronic inflammation in the conjunctiva.
RESPONSES TO ALLERGIC MEDIATORS
Conjunctival goblet cell mucin (MUC5AC) production is dependent upon the rate of mucin synthesis, mucin secretion, goblet cell proliferation, and goblet cell apoptosis. Allergic mediators could directly interact with the goblet cells to increase the amount of mucin on the ocular surface by increasing mucin synthesis and secretion as well as by increasing cell proliferation and decreasing apoptosis.
Mucin synthesis and secretion
There have been no published studies on the regulation of conjunctival goblet cell mucin synthesis in ocular allergy either in vivo or in cell culture. In health, activation of corneal afferent sensory nerves stimulates goblet cell secretion by the activation of efferent parasympathetic nerves that release cholinergic and vasoactive intestinal peptide (VIP)ergic Eye allergy neurotransmitters [26] [27] [28] . Exogenous addition of agonists of muscarinic and VIP receptors also elevates secretion [28] [29] [30] . In allergic conjunctivitis, both dromic activation of nerves and antidromic release of neurotransmitters could stimulate goblet cell secretion. As itch and pain are two neurally mediated symptoms of allergic conjunctivitis, activation of corneal or conjunctival sensory nerves by allergic mediators to cause a reflex stimulation of goblet cells via the efferent parasympathetic nerves could be a mechanism by which goblet cell secretion could be increased in allergic conjunctivitis. In addition, the neurotransmitters substance P and calcitonin gene-related peptide (CGRP) could be released from the corneal and conjunctival sensory nerve endings by neurogenic inflammation and could interact directly with the goblet cells. To understand the role of goblet cell secretion in ocular allergy, the role of sensory nerves and their neurotransmitters is critical to investigate.
An important pathway shown to stimulate goblet cell secretion is release of mediators and cytokines from infiltrating immune cells such as mast cells, eosinophils, neutrophils, T cells, and macrophages [31] . The most thoroughly studied allergic mediator is histamine that can be released by mast cells and basophils. All four histamine receptors (H1-H4) are present in both rat and human goblet cells [32] . Histamine itself and agonists of all four histamine receptors each stimulate goblet cell secretion and antagonists block histamine-stimulated goblet cell secretion [32] . Histamine induces mucin secretion by increasing the intracellular [Ca 2þ ] and activating extracellular regulated kinase (ERK1/2) [33, 34 && ]. Thus, goblet cells are a direct target of one of the important allergic mediators, histamine.
Other proinflammatory mediators produced by infiltrating immune cells, in addition to histamine, stimulate goblet cell secretion. Mast cells and eosinophils can produce the cysteinyl leukotrienes LTC4, LTD4, and LTE4. The receptors for the cysteinyl leukotrienes Cys-LT1 and Cys-LT2 are both present on conjunctival goblet cells [35] . LTC4, LTD4, and LTE4 each stimulates conjunctival goblet cell secretion. LTD4 and to some extent LTE4 use the Cys-LT1 receptor. In addition, the leukotriene LTB4 and the proinflammatory prostaglandin D2 also stimulate goblet cell secretion, but their mechanisms of action have yet to be determined.
Goblet cell proliferation and apoptosis
Conjunctival goblet cells are able to proliferate both in vivo [36] and in cell culture. Evidence shows that the growth factor epidermal growth factor (EGF) stimulates goblet cell proliferation in culture The number of filled conjunctival goblet cells was increased in the challenged compared with naïve mice, suggesting that allergic mediators stimulate goblet cell proliferation. Although the effects of histamine, leukotrienes, and prostaglandins on goblet cell proliferation in culture have yet to be tested, as discussed previously the Th2 cytokine IL-13 increases mouse conjunctival goblet cell proliferation [16 && ] and IL-13 knockout mice have a decrease in conjunctival goblet cells [42] .
Alteration in conjunctival goblet cell apoptosis could also change mucin production. As discussed previously, Contreras-Ruiz [16 && ] found that the Th2 cytokine IL-13 decreased goblet cell apoptosis. Thus, IL-13 has a coordinated effect on conjunctival goblet cells to increase mucin production by stimulating cell proliferation and inhibiting cell apoptosis. It is important to investigate the effect of other allergic mediators on goblet cell proliferation and apoptosis to determine whether in ocular allergy there is a multipronged, coordinated regulation of goblet cell mucin production by increasing mucin synthesis and secretion, along with increasing cellular proliferation and decreasing apoptosis similar to the effect of cytokines in the mouse model of Sjogren's syndrome.
CONCLUSION
Conjunctiva with its specialized goblet cells and lymphoid tissue is a major, critical component in the response of the ocular surface to controlling chronic inflammation, including ocular allergy. Goblet cell production of the secretory mucin MUC5AC protects the ocular surface and is a target of regulation by allergic and inflammatory mediators produced by the local innate and adaptive immune cells. These mediators alter goblet cell proliferation, secretion, and cell survival. Allergic mediators including histamine, leukotrienes, and prostaglandins directly stimulate goblet cell secretion. Inflammatory cytokines can regulate secretion, proliferation, and apoptosis of these cells. In particular, the opposing effects of IL-13, TNFa, and IFNb on goblet cell survival control the changes in goblet cell number and tear MUC5AC that occur over time in chronic inflammatory diseases of the ocular surface. Preclinical mouse models of ocular surface inflammation and allergy along with the conjunctival goblet cell culture provide a unique opportunity to evaluate and understand the goblet cell responses to acute and chronic inflammation in the conjunctiva.
